Acquisitions

We focus on new technologies which enjoy some amount of human clinical trial data.  Your data does not need to be complete Phase III clinical trial data, but the data must at minimum be reliable both scientifically and legally.  Scientifically, this means that your data should not have obvious sampling or measurement biases, and the data set should be large enough to provide, if not statistical reliability, a sense the results are not mere random variation.  Legally, this means your data must have been gathered in compliance with regulatory requirements for human clinical testing.

In contrast, if you have only laboratory animal data, we would unfortunately likely not be a suitable partner for developing your new technology.

Given these constraints, we are quite open in therapeutic category: we consider products as diverse as injectable chemotherapeutic drugs and topical dermatology drugs, implantable therapeutic devices and diagnostic devices.